Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 23 min ago
Peer-reviewedCC BY 4.0PLOS Digital Health

Utilising digital technologies for mycetoma management: A comprehensive review of advances and opportunities

6 affiliations
  1. 1Faculty of Medicine and Surgery, Al-Neelain University, Khartoum, Sudan
  2. 2The Mycetoma Research Center, University of Khartoum, Khartoum, Sudan
  3. 3Faculty of Pharmacy, National University, Khartoum, Sudan
  4. 4Faculty of Medicine, University of Khartoum, Khartoum, Sudan
  5. 5Periodontology and Oral Medicine, Department of Periodontology, Faculty of Dental Medicine and Surgery, Centre for Professional Development, National University-Sudan, Khartoum, Sudan
  6. 6Department of Clinical Pharmacy, Faculty of Pharmacy, Omdurman Islamic University, Khartoum, Sudan

Abstract

Mycetoma is a neglected tropical disease characterised by chronic, destructive infections of subcutaneous tissues, predominantly affecting populations in endemic regions with limited healthcare resources. Delayed diagnosis, limited treatment options, and restricted access to specialised healthcare contribute to substantial morbidity, disability, and socioeconomic burden. Digital technologies offer promising opportunities to address these challenges and improve mycetoma care. Artificial intelligence (AI) can support early detection and diagnostic accuracy through the analysis of clinical images, radiological findings, and patient data. Telemedicine can facilitate remote specialist consultations and follow-up, particularly in rural and underserved communities, while electronic health records enable systematic data collection, disease surveillance, and monitoring of treatment outcomes. Mobile health applications can improve patient education, symptom monitoring, and treatment adherence, whereas computational drug discovery may accelerate the identification of potential therapeutic agents. Furthermore, digital platforms can strengthen international research collaborations, knowledge exchange, and capacity building. However, implementing these technologies in endemic regions faces significant barriers, including inadequate digital infrastructure, limited internet connectivity, insufficient digital literacy, data privacy concerns, and ethical challenges related to informed consent, data ownership, and algorithmic decision-making. Addressing these barriers requires investment in infrastructure, appropriate regulatory frameworks, stakeholder collaboration, and context-specific capacity-building initiatives. Integrating digital health solutions into national healthcare strategies could support sustainable and equitable improvements in mycetoma management. This review highlights the potential applications, opportunities, and challenges of digital technologies in mycetoma care and emphasises the need for inclusive, locally adapted approaches to enhance early diagnosis, treatment outcomes, research, and health equity in endemic communities.

Related

  1. Integration of STEM technologies in chemistry education: opportunities, challenges, and future directions
    Bakytgul Kabykenovna Massalimova, A.S. Darmenbayeva, Irina Afanasenkova +9
    Frontiers in EducationPeer-reviewedCC BYFull text5 citedPhysical chemistryOpenAlex
  2. Hybrid Joining Technologies for Composites: Mechanisms, Performance, Challenges, and Perspectives
    Irfan Nazir Wani, Jogendra Kumar, Pulak Gupta
    ChemRxivPreprintLicence not statedGeneral chemistryChemRxiv
  3. Single Cell Proteomics to Spatial Multiomics in Cardiovascular Disease: Foundations, Technologies, and Biological Insights
    Aleksandra Binek, Peggi M. Angel
    Circulation researchPeer-reviewedLicence not statedFull text2 citedPhysical chemistryPMC
  4. Winery By-Products as Sustainable Functional Resources: An Overview of Composition, Green Extraction Technologies, and Industrial Valorization
    Vanessa Hobeika, Nancy Zgheib, Nancy Nehme +3
    Molecules (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral chemistryEurope PMC
  5. Emerging Processing Technologies for Modulating Allergenic Proteins in Legumes and Gluten-Containing Cereals: A Systematic Review
    Jose Aaron Ortiz-Zapata, Rebeca Salvador-Reyes, Marcio Schmiele +6
    Molecules (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral chemistryEurope PMC
BibTeX
@article{zamel2026utilising,
  title = {{Utilising digital technologies for mycetoma management: A comprehensive review of advances and opportunities}},
  author = {Ahmad Mohammad Al Zamel and Ali Awadallah Saeed and Malaz Abdelrahman Ahmed and Samira Mohammed and Eman Kheir and Safaa Badi and Ahmed Hassan Fahal},
  journal = {PLOS Digital Health},
  year = {2026},
  month = nov,
  doi = {10.1371/journal.pdig.0001822},
  url = {https://journals.plos.org/digitalhealth/article?id=10.1371/journal.pdig.0001822},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Utilising digital technologies for mycetoma management: A comprehensive review of advances and opportunities
AU  - Ahmad Mohammad Al Zamel
AU  - Ali Awadallah Saeed
AU  - Malaz Abdelrahman Ahmed
AU  - Samira Mohammed
AU  - Eman Kheir
AU  - Safaa Badi
AU  - Ahmed Hassan Fahal
PY  - 2026
DA  - 2026/11/06
JO  - PLOS Digital Health
DO  - 10.1371/journal.pdig.0001822
UR  - https://journals.plos.org/digitalhealth/article?id=10.1371/journal.pdig.0001822
AB  - Mycetoma is a neglected tropical disease characterised by chronic, destructive infections of subcutaneous tissues, predominantly affecting populations in endemic regions with limited healthcare resources. Delayed diagnosis, limited treatment options, and restricted access to specialised healthcare contribute to substantial morbidity, disability, and socioeconomic burden. Digital technologies offer promising opportunities to address these challenges and improve mycetoma care. Artificial intelligence (AI) can support early detection and diagnostic accuracy through the analysis of clinical images, radiological findings, and patient data. Telemedicine can facilitate remote specialist consultations and follow-up, particularly in rural and underserved communities, while electronic health records enable systematic data collection, disease surveillance, and monitoring of treatment outcomes. Mobile health applications can improve patient education, symptom monitoring, and treatment adherence, whereas computational drug discovery may accelerate the identification of potential therapeutic agents. Furthermore, digital platforms can strengthen international research collaborations, knowledge exchange, and capacity building. However, implementing these technologies in endemic regions faces significant barriers, including inadequate digital infrastructure, limited internet connectivity, insufficient digital literacy, data privacy concerns, and ethical challenges related to informed consent, data ownership, and algorithmic decision-making. Addressing these barriers requires investment in infrastructure, appropriate regulatory frameworks, stakeholder collaboration, and context-specific capacity-building initiatives. Integrating digital health solutions into national healthcare strategies could support sustainable and equitable improvements in mycetoma management. This review highlights the potential applications, opportunities, and challenges of digital technologies in mycetoma care and emphasises the need for inclusive, locally adapted approaches to enhance early diagnosis, treatment outcomes, research, and health equity in endemic communities.
SN  - 2767-3170
ER  -